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INTRODUCTION
The prevalence of asthma continues to rise. A number of
environmental factors including air pollution, cigarette smok-
ing, and allergen exposure have been proposed to explain the
changes in the prevalence of asthma (1). The prevalence of
asthma has increased in Korea from 5.7% in 1980 to 10.0%
in 1995 (2).
Passive smoking is a major cause of respiratory morbidity
in children. High levels of parental smoking at home are asso-
ciated with a reduction in health care contacts for asthma.
Children with asthma who have parents who smoke heavily
may not be receiving adequate management (3). The smok-
ing rate among parents of asthmatic children is significantly
higher than among parents of normal children (4).
An increase in the total IgE in relation to active smoking
has been demonstrated in the general population. An increase
in IgE was also observed in first-degree relatives exposed to
passive smoking (5).
Passive smoking increases the likelihood of experiencing
respiratory symptoms and is associated with increased bronch-
ial responsiveness. Decreasing involuntary exposure to tobacco
smoke in the community, especially in the workplace, should
improve respiratory health (6).
To investigate the effect of exposure to parental cigarette
smoking on asthma symptoms, we gave schoolchildren ques-
tionnaires that asked about asthma symptoms, atopy, and air-
way hyperresponsiveness. 
MATERIAL AND METHODS
Study population and Questionnaire
All children were 10-12 yr of the age. The question on respi-
ratory and allergic disorders included those developed for the
International Study of Asthma and Allergies in Childhood
(ISAAC). The focus of this survey was on responses to the
ISAAC questions on ‘‘wheeze in the last 12months’’, ‘‘number
of wheezing attacks in the last 12 months’’, and on ‘‘sleep-
disturbing’’ and ‘‘speech-limiting’’ wheezing in the last 12
months. Symptoms of allergic rhinitis (‘‘sneezing or runny,
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The Effect of Passive Smoking on Asthma Symptoms, Atopy, and
Airway Hyperresponsiveness in Schoolchildren 
Passive smoking is a major cause of respiratory morbidity, and is associated with
increased bronchial responsiveness in children. To evaluate the effect of smoking
by a parent on asthma symptoms, atopy, and airway hyperresponsiveness (AHR),
we conducted a cross-sectional survey of 503 schoolchildren that involved question-
naires, spirometry, allergy testing, and a bronchial challenge test. If the PC20 metha-
choline was less than 16 mg/mL, the subject was considered to have AHR. The
prevalence of a parent who smoked was 68.7%. The prevalence of AHR was 45.0%.
The sensitization rate to common inhalant allergens was 32.6%. Nasal symptoms
such as rhinorrhea, sneezing, nasal itching, and nasal obstruction were present in
42.7%. Asthma symptoms such as cough and wheezing were present in 55.4%. The
asthma symptoms were significantly more prevalent in children who had a parent
who smoked than in those whose parents did not. The nasal symptoms, atopy, and
AHR did not differ according to whether a parent smoked. In a multiple logistic regres-
sion model, the asthma symptoms and atopy were independently associated with
AHR, when adjusted for confounding variables. Passive smoking contributed to asth-
ma symptoms in schoolchildren and was not an independent risk factor of airway
hyperresponsiveness in an epidemiological survey.
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or blocked nose without a cold’’) were assessed (7). In addition,
a question on morning cough as a symptom of nonspecific
airway irritation was asked (‘‘Did you frequently cough in the
morning right after waking up in the last 12 months?’’). Also
a question on smoking status of parents was asked. A total of
503 schoolchildren was enrolled in this study (Table 1). No
subjects took any drugs within 72 hr of tests such as anti-
histamine, cromolyn, theophylline, sympathomimetics,
which could interfere with the performance of skin tests. The
all guardians signed informed consent before the study. 
Pulmonary function study 
Spirometry was performed with SensorMedics 2200 spirom-
eter (Cardiopulmonary care companyTM, Yorba Linda, Califor-
nia, U.S.A.). Baseline measurements of VC and FEV1 were
selected according to American Thoracic Society criteria (8)
and reference values were taken from Choi et al. (9).
Allergy skin prick test
Allergy skin prick tests were performed with eleven com-
mon allergen extracts [Dermatophagoides farinae, Dermato-
phagoides pteronyssinus, Aspergillus spp, alder, birch, hazel, rye,
timothy, mugwort, ragweed, Blatella germinica; Aller-
gopharma Co, Reinbek, Germany], and histamine (1 mg/mL)
and saline as a positive control and a negative control. The reac-
tions were read 15 min later. When the wheal size was equal
or greater than that of histamine (positive control), it was read
as 3+. Atopy was defined as a reactor who showed ≥3+
response to one or more allergens on skin prick tests (10). 
Airway hyperresponsiveness 
Methacholine challenge tests were carried out by a modi-
fied method described by Chai et al. (11). Concentrations of
0.075, 1.25, 2.5, 5, 10 and 25 mg/mL methacholine were
prepared by dilution with buffered saline. A Micro-dosime-
ter (S&M Instrument Co, Doylestown, PA) was used to deliver
the aerosol generated by a DeVilbiss 646 nebulizer. Subjects
inhaled 5 breaths of increasing concentrations of methacholine
until FEV1 fell by more than 20% of its basal value or the
highest concentration was reached. The largest value of tripli-
cate FEV1 at 30 or 90 or 180 sec after each inhalation was
adopted for analysis. If PC20 was less than 16 mg/mL, a sub-
ject was considered to have AHR.
Statistical analyses
All data were analyzed using the SPSS version 7.5 for Win-
dows. Each biochemical assays were repeated at least two
times. Data are expressed as mean±standard error of mean
(SEM). Statistical analysis was performed by Student’s t test,
Mann-Whitney U test. In multivariate analysis, logistic regres-
sion was performed with a stepwise selection method with
p<0.05 for entry into the model. Atopy and asthma symptoms
were treated as binary outcome variables in logistic regression
analysis. A p-value of <0.05 considered to be significant.
RESULTS
The characteristics of children of school age were shown
in Table 1. The prevalence of parent’s smoking was 68.7%
(346/503). The prevalence of AHR was 45.0% (227/503).
The sensitization rate (skin prick test A/H ≥3+) to common
inhalant allergens were 32.6% (164/503). Nasal symptoms
such as rhinorrhea, sneezing, nasal itching, and nasal obstruc-
tion were present in 42.7%. Asthma symptoms such as cough-
ing, wheezing, and chest tightness were present in 55.4%.
The asthma symptoms were significantly more prevalent in
children who had a parent who smoked than in those whose
parents did not [(205/350 (58.5%) vs. 74/157 (47.1%), p=
0.016)]. The nasal symptoms, atopy, and AHR did not differ
according to whether a parent smoked. In a multiple logistic
regression model, the asthma symptoms and atopy were inde-
pendently associated with AHR, when adjusted for confound-
ing variables (OR=1.895; 95% CI=1.213-3.801, p=0.046;
OR=1.657; 95% CI=1.332-2.956, p=0.029, Table 2).
Parent smoking (+) Parent smoking (-)
Age (yr) 10.96±0.04 10.90±0.06
Sex (M/F) 162/188 83/70
Asthma symptoms (%) 58.5 48.3
Nose symptoms (%) 63.7 58.8
Atopy (%) 31.7 34.6
PC20 (mg/mL) 16.7±0.54 16.6±0.79
FEV1 (%pred) 102.8±0.46 104.5±0.06
FVC (%pred) 105.8±0.38 103.8±0.46 
FEV1/FVC 97.7±0.4 98.6±0.6
Table 1. Characteristics of school children
% pred, group mean value of individual percentage predicted lung func-
tion parameter; FEV1, forced expiratory volume in one second; FVC, forced
vital capacity; M, male; F, female.
Odd ratios Variables 95% confidence interval
Age 1.147 0.912-1.451
Sex 1.050 0.727-1.494
Status of parent’s smoking 1.136 0.783-1.642
Asthma symptoms* 1.895 1.213-3.801
Family history
� 0.865 0.529-1.521
FEV1% predicted 0.980 0.958-1.114
Atopy* 1.657 1.332-2.956
Table 2. Multivariate logistic regression on airway hyperrespon-
siveness
Stepwise logistic regression was used to select factors significantly asso-
ciated AHR risk (*p<0.05). 
� defined by having or not parent’s allergic dis-
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DISCUSSION
This epidemiological survey demonstrated that passive
smoking contributes to asthma symptoms and is not an inde-
pendent risk factor of AHR in schoolchildren.
The prevalence of asthma has increased dramatically in
recent years, especially among children. In our study, the preva-
lence of a PC20 less than 16 mg/mL was 45.0%, which repre-
sents the AHR prevalence among schoolchildren according
to the American Thoracic Society criteria (12). Long-term
follow up to clarify the association between AHR and asthma
in schoolchildren is needed. The factors leading to the increase
in asthma and allergies have not been identified, although
exposure related to general changes in the domestic environ-
ment is likely involved. Environmental factors play an impor-
tant role in the development and manifestation of allergic con-
ditions in genetically predisposed subjects (13). Passive smok-
ing increases the risk of allergic sensitization. It also increases
the frequency and severity of symptoms in children with asth-
ma (14). In this study, the observed prevalence of atopy in
schoolchildren was 32.6%, and atopy was an independent
risk factor in AHR, indicating that atopy plays an important
role in the development of asthma in schoolchildren. We did
not observe an effect of parental smoking on atopy in school-
children. Exposure to tobacco smoke has been associated with
a decline in peak flow and with increases in respiratory symp-
toms and bronchodilator use in asthmatic children (15). In
most of the families that we studied in which a parent smoked,
the father smoked (97%). Although parental smoking did
not affect AHR, it was associated with asthma symptoms.
Whether a parent smoked had no effect on AHR in children.
Therefore, our data suggest that parental smoking does not
cause asthma, but aggravates it.
The risk of asthma in Nepalese children was lower in sub-
jects exposed to cattle kept inside the house and higher in
subjects exposed to passive smoking and indoor use of smoky
fuels (16). Another study found that the risk factors for child-
hood asthma increased with increasing numbers of smokers
and the total minutes spent smoking by relatives in front of
both the child and the mother while she was pregnant with
the child (17). We did not measure the total minutes or am-
ount of smoking by parents in front of children. Further study
is needed to clarify the effects of exposure time and the amount
of passive smoking on AHR. A greater baseline exposure to
environmental tobacco smoke has also been related with poorer
physical health and asthma-specific quality-of-life at longitu-
dinal follow up (18). In our study, having a parent who smoked
was not a risk factor for AHR, but contributed to asthma
symptoms. This suggests that it is necessary to prohibit par-
ents from smoking to prevent asthma-related symptoms in
children. These findings emphasize the need for continuing
effort to decrease exposure to passive smoke among schoolchil-
dren and to increase understanding of the harmful health
effects of smoking exposure. Parents of children with asthma
should be advised not to smoke, especially in rooms that their
children use.
Kurukulaaratchy et al. (19) reported factors that influenced
symptom expression in children with bronchial hyperrespon-
siveness at 10 yr of age. When only factors present in the first
4 yr of life were considered, parental smoking at 4 yr of age,
maternal asthma, and atopic sensitization at 4 yr of age were
independently associated with symptomatic AHR at 10 yr
of age. In our study, although asthma symptoms and atopy
were independent risk factors for AHR, parents’ smoking
status was not. We evaluated exposure to passive smoking
with a questionnaire that did not distinguish between current
and former smokers. Further studies are needed to clarify the
role of passive smoking in the development of AHR.
In conclusion, we found that passive smoking was associ-
ated with asthma symptoms and that parents’ smoking was
not a risk factor in AHR, suggesting that further effort should
be made to convince the parents of asthmatic children not to
smoke in the house.
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